0001209191-20-021118.txt : 20200325
0001209191-20-021118.hdr.sgml : 20200325
20200325164105
ACCESSION NUMBER: 0001209191-20-021118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200323
FILED AS OF DATE: 20200325
DATE AS OF CHANGE: 20200325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDevitt Damien
CENTRAL INDEX KEY: 0001742277
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 20742605
MAIL ADDRESS:
STREET 1: C/O IONIS PHARMACEUTICALS, INC.
STREET 2: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-23
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001742277
McDevitt Damien
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
1
1
0
0
Chief Executive Officer
Common Stock
2020-03-23
4
S
0
9417
11.7499
D
245783
D
Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019.
/s/ Joshua F. Patterson, Attorney-in-Fact
2020-03-25